Dementia pill could save lives by reducing risk of heart attacks and strokes | Health | News | Daily Express

| June 5, 2013 | 1 Comment

The simple drug could be harnessed to beat devastating heart conditions

Ground-breaking research has discovered that the tablets – which can cost as little as 32p a day – can slow the symptoms of the killer ain disease and have the added benefit of protecting against heart and cardiovascular problems.

It means the simple drugs could be harnessed as a new weapon to beat devastating heart conditions which kill at least 160,000 people each year in the UK.

Scientists from Umea University in Sweden studied more than 7,000 Alzheimer’s sufferers.

They found that those taking drugs called cholinesterase inhibitors (ChEIs), which are used for treating mild to moderate Alzheimer’s disease, had a 36 per cent reduced risk of death from any cause.

They also had a 38 per cent lower risk of a heart attack and a 26 per cent reduced risk of death from cardiovascular causes such as stroke compared to people not taking the drugs.

Patients taking the highest recommended doses had the lowest risk of heart attack or death – 65 per cent and 46 per cent lower respectively – compared with those who had never used the drugs such as donepezil (Aricept), rivastigmine (Exelon) and galantamine (Reminyl).

Lead researcher Professor Peter Nordstrom, said: “If you translate these reductions in risk into absolute figures, it means for every 100,000 people with Alzheimer’s disease, there would be 180 fewer heart attacks – 295 as opposed to 475 – and 1,125 fewer deaths from all causes – 2,000 versus 3,125 – every year among those taking ChEIs compared to those not.”

There are at least 850,000 people in Britain with dementia


Category: Articles, Research News